MSTN and congestive heart failure: In particular, increased levels of cardiac derived myostatin act in an endocrine fashion on skeletal muscle to reduce muscle mass, in this way inducing a progressive skeletal muscle atrophy in patients with chronic heart failure [105,106,107].